Page last updated: 2024-11-04

vorinostat and Endometriosis

vorinostat has been researched along with Endometriosis in 2 studies

Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).

Endometriosis: A condition in which functional endometrial tissue is present outside the UTERUS. It is often confined to the PELVIS involving the OVARY, the ligaments, cul-de-sac, and the uterovesical peritoneum.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Imesch, P1
Samartzis, EP1
Dedes, KJ1
Fink, D1
Fedier, A1
Kawano, Y1
Nasu, K1
Li, H1
Tsuno, A1
Abe, W1
Takai, N1
Narahara, H1

Other Studies

2 other studies available for vorinostat and Endometriosis

ArticleYear
Histone deacetylase inhibitors down-regulate G-protein-coupled estrogen receptor and the GPER-antagonist G-15 inhibits proliferation in endometriotic cells.
    Fertility and sterility, 2013, Volume: 100, Issue:3

    Topics: Benzodioxoles; Cell Line, Transformed; Cell Proliferation; Depsipeptides; Down-Regulation; Drug Eval

2013
Application of the histone deacetylase inhibitors for the treatment of endometriosis: histone modifications as pathogenesis and novel therapeutic target.
    Human reproduction (Oxford, England), 2011, Volume: 26, Issue:9

    Topics: Acetylation; Adult; Apoptosis; Cell Cycle Checkpoints; Cell Proliferation; Checkpoint Kinase 2; Cycl

2011